Loading…
Prescriptions analysis by clinical pharmacists in the post-operative period: a 4-year prospective study
Background Clinical pharmacists can help prevent medication errors. However, data are scarce on their role in preventing medication prescription errors in the post‐operative period, a high‐risk period, as at least two prescribers can intervene, the surgeon and the anesthetist. We aimed to describe a...
Saved in:
Published in: | Acta anaesthesiologica Scandinavica 2012-09, Vol.56 (8), p.1047-1051 |
---|---|
Main Authors: | , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Background
Clinical pharmacists can help prevent medication errors. However, data are scarce on their role in preventing medication prescription errors in the post‐operative period, a high‐risk period, as at least two prescribers can intervene, the surgeon and the anesthetist. We aimed to describe and quantify clinical pharmacist' intervention (PIs) during validation of drug prescriptions on a computerized physician order entry system in a post‐surgical and post‐transplantation ward. We illustrate these interventions, focusing on one clearly identified recurrent problem.
Methods
In a prospective study lasting 4 years, we recorded drug‐related problems (DRPs) detected by pharmacists and whether the physician accepted the PI when prescription modification was suggested.
Results
Among 7005 orders, 1975 DRPs were detected. The frequency of PIs remained constant throughout the study period, with 921 PIs (47%) accepted, 383 (19%) refused and 671 (34%) not assessable. The most frequent DRP concerned improper administration mode (26%), drug interactions (21%) and overdosage (20%). These resulted in a change in the method of administration (25%), dose adjustment (24%) and drug discontinuation (23%) with 307 drugs being concerned by at least one PI. Paracetamol was involved in 26% of overdosage PIs. Erythromycin as prokinetic agent, presented a recurrent risk of potentially severe drug–drug interactions especially with other QT interval‐prolonging drugs. Following an educational seminar targeting this problem, the rate of acceptation of PI concerning this DRP increased.
Conclusion
Pharmacists detected many prescription errors that may have clinical implications and could be the basis for educational measures. |
---|---|
ISSN: | 0001-5172 1399-6576 |
DOI: | 10.1111/j.1399-6576.2011.02644.x |